BridgeBio Pharma Inc.

NASDAQ: BBIO · Real-Time Price · USD
51.48
0.30 (0.59%)
At close: Aug 15, 2025, 1:04 PM

BridgeBio Pharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-9.53 -10.22 -2.27 -3.77
PEG Ratio
0.35 -0.57 0.09 -0.47
PS Ratio
23.01 706.43 14.47 34.54
PB Ratio
-3.5 -4.85 -0.9 -2.77
P/FCF Ratio
-9.79 -12.42 -2.64 -4.41
P/OCF Ratio
-9.81 -12.45 -2.68 -4.84
OCF/S Ratio
-2.35 -56.73 -5.4 -7.14
Debt / Equity Ratio
-1.19 -1.28 -1.37 -1.98
Quick Ratio
4.67 3.32 3.97 6.98
Current Ratio
4.67 3.32 4.29 6.45
Asset Turnover
0.24 0.02 0.12 0.07
Interest Coverage
-5.97 -7.47 -5.87 -12.39
Return on Equity
0.37 0.47 0.39 0.73
Return on Assets
-0.58 -1.18 -0.79 -0.63
Return on Invested Capital
-0.78 -1.49 -0.94 -0.71
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.98 0.74 0.96 0.96
Net Profit Margin
-2.41 -69.14 -6.36 -9.17
Pretax Profit Margin
-2.44 -70.22 -6.24 -8.41
Operating Profit Margin
-2.67 -65.29 -6.08 -8.32
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.97 -60.78 -5.12 -7.66